Article · 13 Feb 2026
Mini reviewPublished 31 Jul 2024
Improving Virtual Bioequivalence for Orally Administered Drugs
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Virtual bioequivalence assessments have emerged as a valuable tool in the pharmaceutical industry, particularly for evaluating orally administered drugs. This approach leverages computational modeling and simulation to predict how different drug formulations compare to each other in terms of their pharmacokinetic profiles. The primary advantage of virtual bioequivalence is its potential to reduce the need for extensive in vivo testing, thereby accelerating drug development and lowering costs. However, ensuring the accuracy and reliability of these virtual assessments remains a challenge. This article explores current methodologies for virtual bioequivalence, discusses their benefits and limitations and proposes strategies for improving their efficacy. Advances in computational power, modeling techniques and integration of real-world data are highlighted as key factors that could enhance the precision of virtual bioequivalence evaluations.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pepin Huckle”

